VCI Global Showcases Integrated AI and Cybersecurity Platforms at Smart City Expo KL 2025 9-09-2025, 04:00

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26

Global Cellular IoT Industry Anticipated to Hit US $15.4 Bn 7-02-2023, 06:47